BRIMONIDINE TARTRATE AND TIMOLOL MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Brimonidine Tartrate And Timolol Maleate, and what generic alternatives are available?
Brimonidine Tartrate And Timolol Maleate is a drug marketed by Alembic, Apotex, Florida, Sandoz, Sentiss, and Upsher Smith Labs. and is included in six NDAs.
The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brimonidine Tartrate And Timolol Maleate
A generic version of BRIMONIDINE TARTRATE AND TIMOLOL MALEATE was approved as brimonidine tartrate; timolol maleate by SANDOZ on April 4th, 2022.
Summary for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 6 |
| Patent Applications: | 42 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE? | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE excipients list |
| DailyMed Link: | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE at DailyMed |
Recent Clinical Trials for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Allergan | Phase 3 |
| Allergan | |
| Allergan | Phase 4 |
See all BRIMONIDINE TARTRATE AND TIMOLOL MALEATE clinical trials
Pharmacology for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
| Drug Class | alpha-Adrenergic Agonist beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
US Patents and Regulatory Information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 215230-001 | Aug 25, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 091087-001 | Apr 4, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Apotex | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 091442-001 | Apr 20, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Florida | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 201949-001 | Oct 4, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Upsher Smith Labs | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 215598-001 | Dec 12, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sentiss | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 091086-001 | Oct 31, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
